Symbols

OPT(Delisted)

Opthea·NASDAQ

--(--)

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About OPT

Opthea Limited

A clinical stage biopharmaceutical company that develops novel therapies to treat highly prevalent and progressive retinal diseases

Industry

Established Date

Listing Date

10/16/2020

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

06-30

Website

www.opthea.com

Security Type

Depository Receipts (Ordinary Shares)

Office address

Level 9 , 505 Little Collins Street, Melbourne, VIC 3000, Australia

Business

Drug development

Introduction

Opthea Limited was incorporated under the laws of Australia in 1984 as Circadian Technologies Limited. The company is a clinical-stage biopharmaceutical company developing a novel therapy for the treatment of highly prevalent and progressive retinal diseases.

Company Financials

EPS

OPT has released its 2022 Q2 earnings. EPS was reported at -0.11, versus the expected 0, missing expectations. The chart below visualizes how OPT has performed over recent quarters, highlighting trends in earnings surprises.